Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,410 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

NCT02309177

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • UC Davis Cancer Center Sacramento, California, United States
  • University of California Los Angeles Santa Monica, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center and Research Institute University of South Florida Tampa, Florida, United States
View all 15 locations
View Trial Details
Completed

Cancer Symptom Data From Multiple Treatment Centers

NCT01547845

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • St. Joseph's Orange Orange, California, United States
  • Penrose Cancer Center Colorado Springs, Colorado, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Christiana Care Health Services Newark, Delaware, United States
View all 15 locations
View Trial Details
Completed

Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions

NCT01017185

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +20 more
Locations
  • Montefiore Medical Center The Bronx, New York, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
View Trial Details
Completed

Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer

NCT00083031

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions